{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:42:27Z","timestamp":1761129747597,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004396","name":"Thailand Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004396","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.vaccine.2020.05.054","type":"journal-article","created":{"date-parts":[[2020,6,7]],"date-time":"2020-06-07T07:32:13Z","timestamp":1591515133000},"page":"5015-5020","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Immunogenicity and safety of two-visit, intradermal pre-exposure rabies prophylaxis simultaneously administrated with chimeric live-attenuated Japanese encephalitis vaccine in children living in rabies and Japanese encephalitis endemic country"],"prefix":"10.1016","volume":"38","author":[{"given":"Piyada","family":"Angsuwatcharakon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natchaya","family":"Ratananpinit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sutee","family":"Yoksan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wachiraporn","family":"Saengseesom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roongrawee","family":"Sriaksorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nattasri","family":"Raksahket","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terapong","family":"Tantawichien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.05.054_b0005","doi-asserted-by":"crossref","unstructured":"The World Health Organization. Rabies vaccines: WHO position paper, April 2018 - Recommendations. Vaccine. 2018;36(37):5500-3.","DOI":"10.1016\/j.vaccine.2018.06.061"},{"issue":"1","key":"10.1016\/j.vaccine.2020.05.054_b0010","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1086\/517179","article-title":"Additional reports of failure to respond to treatment after rabies exposure in Thailand","volume":"28","author":"Hemachudha","year":"1999","journal-title":"Clin Infect Dis."},{"issue":"20","key":"10.1016\/j.vaccine.2020.05.054_b0015","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1056\/NEJM198705143162006","article-title":"Fatal rabies encephalitis despite appropriate post-exposure prophylaxis. A case report","volume":"316","author":"Shill","year":"1987","journal-title":"N Engl J Med."},{"issue":"2","key":"10.1016\/j.vaccine.2020.05.054_b0020","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/clinids\/22.2.228","article-title":"Failure of postexposure treatment of rabies in children","volume":"22","author":"Wilde","year":"1996","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.vaccine.2020.05.054_b0025","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-206191","article-title":"Rabies encephalitis in a child: a failure of rabies post exposure prophylaxis?","volume":"2015","author":"Tinsa","year":"2015","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.vaccine.2020.05.054_b0030","first-page":"1","article-title":"WHO Expert Consultation on Rabies. Second report","volume":"982","author":"The World Health Organization","year":"2013","journal-title":"World Health Organ Tech Rep Ser."},{"key":"10.1016\/j.vaccine.2020.05.054_b0035","unstructured":"The World Health Organization. WHO Expert Consultation on Rabies. Third report. WHO technical series report no.1012 Geneva2018 [22 January 2020]. Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/272364."},{"issue":"5","key":"10.1016\/j.vaccine.2020.05.054_b0040","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.tmaid.2005.06.001","article-title":"Retrospective: animal attacks and rabies exposures in Thai children","volume":"4","author":"Sriaroon","year":"2006","journal-title":"Travel Med Infect Dis."},{"issue":"4","key":"10.1016\/j.vaccine.2020.05.054_b0045","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1580\/1080-6032(2001)012[0239:REITC]2.0.CO;2","article-title":"Rabies exposures in thai children","volume":"12","author":"Pancharoen","year":"2001","journal-title":"Wilderness Environ Med."},{"issue":"9","key":"10.1016\/j.vaccine.2020.05.054_b0050","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.vaccine.2005.03.059","article-title":"Cost comparison of rabies pre-exposure vaccination with post-exposure treatment in Thai children","volume":"24","author":"Chulasugandha","year":"2006","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2020.05.054_b0055","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2471\/BLT.16.173039","article-title":"Pre-exposure rabies prophylaxis: a systematic review","volume":"95","author":"Kessels","year":"2017","journal-title":"Bull World Health Organ."},{"issue":"44","key":"10.1016\/j.vaccine.2020.05.054_b0060","doi-asserted-by":"crossref","first-page":"7140","DOI":"10.1016\/j.vaccine.2010.08.082","article-title":"Rabies vaccines: WHO position paper, October 2010- Recommendations","volume":"28","author":"The World Health Organization","year":"2010","journal-title":"Vaccine"},{"issue":"13","key":"10.1016\/j.vaccine.2020.05.054_b0065","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.vaccine.2013.01.035","article-title":"Rabies neutralizing antibody after 2 intradermal doses on days 0 and 21 for pre-exposure prophylaxis","volume":"31","author":"Wongsaroj","year":"2013","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2020.05.054_b0070","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/INF.0b013e3181906351","article-title":"A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old Thai children, concomitantly with Japanese encephalitis vaccine","volume":"28","author":"Pengsaa","year":"2009","journal-title":"Pediatr Infect Dis J."},{"issue":"12","key":"10.1016\/j.vaccine.2020.05.054_b0075","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/INF.0b013e3181f68e9c","article-title":"Safety and immunogenicity of a single administration of live-attenuated Japanese encephalitis vaccine in previously primed 2- to 5-year-olds and naive 12- to 24-month-olds: multicenter randomized controlled trial","volume":"29","author":"Chokephaibulkit","year":"2010","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.vaccine.2020.05.054_b0080","first-page":"535","article-title":"A rapid reproducible test for determining rabies neutralizing antibody","volume":"48","author":"Smith","year":"1973","journal-title":"Bull World Health Organ"},{"year":"1973","series-title":"Laboratory technique in rabies","author":"Kaplan","key":"10.1016\/j.vaccine.2020.05.054_b0085"},{"key":"10.1016\/j.vaccine.2020.05.054_b0090","first-page":"1","article-title":"WHO Expert Consultation on rabies","volume":"931","author":"The World Health Organization","year":"2005","journal-title":"World Health Organ Tech Rep Ser."},{"issue":"4","key":"10.1016\/j.vaccine.2020.05.054_b0095","doi-asserted-by":"crossref","first-page":"889","DOI":"10.4161\/hv.23087","article-title":"Memory immune response and safety of a booster dose of Japanese encephalitis chimeric virus vaccine (JE-CV) in JE-CV-primed children","volume":"9","author":"Feroldi","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"10.1016\/j.vaccine.2020.05.054_b0100","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jpeds.2007.02.044","article-title":"Pre-exposure rabies vaccination using purified chick embryo cell rabies vaccine intradermally is immunogenic and safe","volume":"151","author":"Kamoltham","year":"2007","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2020.05.054_b0105","unstructured":"Manning SE, Rupprecht CE, Fishbein D, Hanlon CA, Lumlertdacha B, Guerra M, et al. Human rabies prevention--United States, 2008: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2008;57(RR-3):1-28."},{"issue":"18","key":"10.1016\/j.vaccine.2020.05.054_b0110","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1016\/j.vaccine.2006.02.027","article-title":"Survival of neutralizing antibody in previously rabies vaccinated subjects: a prospective study showing long lasting immunity","volume":"24","author":"Suwansrinon","year":"2006","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.vaccine.2020.05.054_b0115","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/S0264-410X(98)00045-0","article-title":"Safety and efficacy of purified Vero cell rabies vaccine given intramuscularly and intradermally. (Results of a prospective randomized trial)","volume":"16","author":"Jaiiaroensup","year":"1998","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2020.05.054_b0120","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/00006454-199811000-00007","article-title":"Persistence of antibodies in children after intradermal or intramuscular administration of preexposure primary and booster immunizations with purified Vero cell rabies vaccine","volume":"17","author":"Sabchareon","year":"1998","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.vaccine.2020.05.054_b0125","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1128\/am.27.3.553-561.1974","article-title":"Antibody response to a human diploid cell rabies vaccine","volume":"27","author":"Cabasso","year":"1974","journal-title":"Appl Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2020.05.054_b0130","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0264-410X(92)90029-J","article-title":"Longevity of rabies antibody titre in recipients of human diploid cell rabies vaccine","volume":"10","author":"Briggs","year":"1992","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2030699X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2030699X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:43:38Z","timestamp":1759401818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2030699X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":26,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0264410X2030699X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.05.054","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and safety of two-visit, intradermal pre-exposure rabies prophylaxis simultaneously administrated with chimeric live-attenuated Japanese encephalitis vaccine in children living in rabies and Japanese encephalitis endemic country","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.05.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}